Organizational integration of acquired biotechnology companies into pharmaceutical companies: The need for a hybrid approach

• 成果类型: Review
• 署名作者: Schweizer, L
• 署名单位: Grenoble Ecole Management; Otto Friedrich University Bamberg
• 刊物名称: ACADEMY OF MANAGEMENT JOURNAL
• ISSN/ISSBN: 0001-4273
• 发表日期: 2005
• 页码: 1051-1074
• 关键词: research-and-development; STRATEGIC ALLIANCES; interorganizational collaboration; complementary assets; absorptive-capacity; corporate-control; mergers; acquisitions; INNOVATION; capabilities

摘要

This analysis of the postacquisition integration of biotechnology companies by pharmaceutical companies addresses new issues in the pharmaceutical and biotechnology industries and includes five in-depth case studies. The guiding research question is how a biotech company is integrated into a pharmaceutical company seeking access to the biotech company's know-how, technologies, and innovative capabilities. I conclude that given the complexity and multifaceted nature of mergers and acquisitions, pharmaceutical companies need to apply a hybrid postacquisition integration approach with simultaneous short- and long-term motives/orientations and segmentation at a different pace across different value chain components.